By Elizabeth Campbell and Whitney Kisling
Nov. 24 (Bloomberg) -- The following companies may have unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 8 a.m. in New York, unless otherwise specified.
Berkshire Hathaway Inc. (BRK/A): The company controlled by billionaire Warren Buffett may rise as much as 20 percent next year if the U.S. stock market rallies, Barron’s reported, without citing anyone. Berkshire’s Class A shares rose $12,500 to $90,000 in regular trading on Nov. 21.
Citigroup Inc. (C US) rallied 55 percent to $5.86. The fifth-largest U.S. bank by market value received $306 billion of U.S. government guarantees for troubled mortgages and toxic assets to stabilize the company as it faced the threat of a breakup or sale.
Other financial shares climbed. Bank of America Corp. (BAC US) added 7.5 percent to $12.33. Merrill Lynch & Co. (MER US) gained 8.5 percent to $9.05. Morgan Stanley (MS US) increased 7.5 percent to $10.80. JPMorgan Chase & Co. (JPM US) advanced 3 percent to $23.40. UBS AG (UBS US) rose 9.2 percent to $10.32.
Cooper Industries Ltd. (CBE US): The maker of Crescent wrenches said fourth-quarter profit will be lower than its previous forecast because of “deteriorating business conditions” from the “unprecedented credit crisis.” The stock rose 5.8 percent to $24.13 in regular trading on Nov. 21.
Eli Lilly & Co. (LLY US): The pharmaceutical company lost a bid at Ontario’s highest court to limit potential damages in a lawsuit filed by patients who claimed they developed diabetes after using Lilly’s Zyprexa schizophrenia drug. The stock rose 1.7 percent to $30.43 in regular trading on Nov. 21.
Foot Locker Inc. (FL US): The owner of the shoe store chain had its debt rating cut to BB- from BB by Standard & Poor’s, which said a further downgrade may be possible. The stock tumbled 28 percent to $5.49 in regular trading on Nov. 21.
Omrix Biopharmaceuticals Inc. (OMRI US) gained 16 percent to $24.55. The maker of bleeding-control products agreed to be acquired by Johnson & Johnson (JNJ US) for $25 a share, or $438 million.
Marsh & McLennan Cos. (MMC US) fell 1.2 percent to $23.64. The second-largest insurance broker cleared the way to raise $500 million selling shares to fund acquisitions of other companies or securities, according to a regulatory filing.
SAIC Inc. (SAI US): The defense contractor specializing in computer services was cut to “underweight” from “neutral” at JPMorgan Chase & Co., which said the company faces uncertainty about government spending. The shares added 4.3 percent to $18.09 in regular trading on Nov. 21.
Target Corp. (TGT US) rose 3 cents to $28. The second- largest U.S. discount chain said it has decided not to further pursue proposals for its real estate by Pershing Square Capital Management LP.
To contact the reporter on this story: Elizabeth Campbell in New York at ecampbell11@bloomberg.net; Whitney Kisling in New York at wkisling@bloomberg.net
Posts
No comments:
Post a Comment